Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSPHENA vs OXALIPLATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSPHENA vs OXALIPLATIN: Safety Overview

Metric OSPHENA OXALIPLATIN
Total FAERS Reports 205 56,406
Deaths Reported 0 6,501
Death Rate N/A 11.5%
Hospitalizations 4 21,980
Average Patient Age 60.0 yrs 61.5 yrs
% Female Patients N/A 42.1%
FDA Approval Date N/A Apr 28, 2011
Manufacturer N/A Camber Pharmaceuticals, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Discontinued